RecruitingNCT03014609

Cardiovascular Risk and Chronic Obstructive Pulmonary Disease

Cardiovascular Risk and Chronic Obstructive Pulmonary Disease (COPD)


Sponsor

University Hospital, Grenoble

Enrollment

150 participants

Start Date

Jan 9, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

The principal objective of the study is to measure parameters of inflammation, oxidative stress, and vascular, respiratory, and peripheral muscle function parameters, and identify parameters indicative of evolving cardiovascular risk (CVR) in COPD patients, using multivariate analysis.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating the risk of heart and blood vessel problems (cardiovascular disease) in patients with COPD (a chronic lung condition), looking at both stable COPD and those admitted to the hospital with a flare-up (acute worsening) of their condition. **You may be eligible if...** - You are a man or woman aged 18 to 85 - You have been diagnosed with COPD (either by lung function testing showing FEV1/FVC below 70%, or a confirmed COPD diagnosis) - If you are being admitted with a COPD flare-up: you have high carbon dioxide levels, low blood pH, and rapid breathing at the time of admission, and your blood gases have stabilized enough for safe participation - You have given your written informed consent **You may NOT be eligible if...** - You are outside the age range of 18 to 85 - You do not have a confirmed COPD diagnosis - Your COPD flare-up is too severe or unstable for safe participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Grenoble Hospital

Grenoble, La Tronche, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03014609


Related Trials